欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体

Anti-CD40 mAbs

简要描述:

This antibody binds the CD40 and blocks the humoral immune responses to T cell dependent antigens in a dose dependent manner.

产品参数:

Cat. No.:MABL-945

Species:Engineer

Species Reactivity:Human

Type:Recombinate

Application:therapeutic, Block

详细介绍

Key features and details


Cat. No.

MABL-945

Name

Anti-CD40 mAbs

Clone No.

AFD- chi220

From

Recombinant Antibody

Isotype

Engineer antibody

Application

therapeutic, Block

Species Reactivity

Human

Basic Information


Specificity

This antibody binds the CD40 and blocks the humoral   immune responses to T cell dependent antigens in a dose dependent manner.

Alternative Name

TNFSF5; CDw40; TRAP; p50; Bp50; CD40L   receptor; Tumor necrosis factor ligand superfamily member 5; B-cell surface   antigen CD40; T-cell antigen Gp39; TNF-related activation protein.

UniProt

P29965

Immunogen

This antibody was generated by immunizing   female BALB/c mice with a fusion protein containing extracellular domain of human   CD40 fused to the hinge CH2 and CH3 domains of a murine IgG2b antibody.

Application Notes

This antibody blocks the interaction between   CD40 and gp39. Chi220 was used either alone or in combination with CTLA4-Ig   in an immunosuppresive therapy study to check the survival of renal   allografts in non human primate models (PMID: 12394833). Chi220 blocks   binding of CD154, it also has partial agonist properties and weak stimulatory   potential. It synergisticaly works with LEA29Y (belatacept) to prolong the   islet allograft survival in a non-human primate Macaca fascicularis (PMID:   15611281). A study on protection of islets xenographs in diabetic macaques   used a combination of Chi220 with IL-2 receptor specific antibody Basiliximab  for immunosuppression with induction therapy. Chi220 is used as an sCD154   blocking agent and it was seen that it binds sCD154 in a dose dependant   manner (PMID: 21920020). 

Antibody First Published

Adams et al. Development of a chimeric   anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet   allograft survival. J Immunol. (2005); 174(1):542-50.PMID:15611281

Note on publication

Describes the generation and   characterization of this antibody.

COA Information For reference only, actual COA shall prevail

Size

100 μg Purified antibody.

Concentration

1 mg/ml.

Purification

Protein A affinity purified

Buffer

PBS with 0.02% Proclin 300.

Concentration

1 mg/ml.

Storage Recommendation

Store at 4⁰C for up to 3 months. For   longer storage, aliquot and store at - 20⁰C.


 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

上一篇: Anti-CD40 mAbs

下一篇: Anti-CD40 mAbs

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号